YM Bio.'b'ser1 News - YMB

YM BIOSCIENCES NIMOTUZUMAB APPROVED FOR MEXICO MARKETING

YM BIOSCIENCES REPORTS NIMOTUZUMAB APPROVED FOR MARKETING IN MEXICO YM Enrolls First Patients in Multinational Randomized, Double-Blind Brain...

YM BIOSCIENCES USA RECEIVES CLEARANCE

YM BIOSCIENCES USA RECEIVES CLEARANCE FROM US TREASURY DEPARTMENT TO EXTEND CLINICAL PROGRAM FOR NIMOTUZUMAB MISSISSAUGA, ON, Aug. 10 /CNW/ - YM...

YM BioSciences' subsidiary resolves proposed arbitration

YM BioSciences' subsidiary resolved proposed arbitration with Oncoscience AG MISSISSAUGA, ON, June 29 /CNW/ - YM BioSciences Inc. (NYSE Amex:YMI...

Statement re YM BioSciences Reports Daiichi-Sankyo

YM BIOSCIENCES REPORTS DAIICHI-SANKYO ENROLLS FIRST PATIENTS IN PHASE II, FIRST-LINE LUNG CANCER TRIAL WITH NIMOTUZUMAB MISSISSAUGA, ON, June 23...

Clinical study results to be presented at annual meeting

YM BIOSCIENCES ANNOUNCES RESULTS OF RANDOMIZED NIMOTUZUMAB STUDY TO BE PRESENTED IN A POSTER AT ASCO ANNUAL MEETING MISSISSAUGA, ON, May 28 /CNW/...

YM BIOSCIENCES ANNOUNCES TRIAL OF NIMOTUZUMAB

YM BIOSCIENCES ANNOUNCES FIRST PATIENT ENROLLED IN MULTI-NATIONAL, RANDOMIZED, DOUBLE-BLIND TRIAL OF NIMOTUZUMAB IN NON-SMALL-CELL LUNG CANCER...

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND...

Half-yearly Report

YM BIOSCIENCES REPORTS SECOND QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS MISSISSAUGA, ON, Feb. 13 /CNW/ - YM BioSciences Inc. (NYSE Alternext...

Research Update

YM BIOSCIENCES RECEIVES CLEARANCE TO INITIATE RANDOMIZED DOUBLE-BLIND CLINICAL TRIALS OF NIMOTUZUMAB IN LUNG CANCER AND BRAIN METASTASES FROM LUNG...

Statement re

YM BIOSCIENCES' NIMOTUZUMAB SELECTED FOR MULTINATIONAL PHASE III TRIAL BY NATIONAL CANCER CENTRE OF SINGAPORE Singapore investigators to...

YM BioSciences Announces Milestone Payment

YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia MISSISSAUGA, Canada, Dec. 12 /CNW/ - YM...

YM BioSciences EU Regulatory Update

YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE MISSISSAUGA, ON, Dec. 5 /CNW/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an...

Notice of YM Biosciences Annual and Special Meeting

Notice of YM Biosciences Annual and Special Meeting of Shareholders MISSISSAUGA, ON, Nov. 17 /CNW/ - YM BioSciences Inc. (NYSE Alternext US:YMI...

YM BIOSCIENCES - INTENTION - ARBITRATION

YM BIOSCIENCES SUBSIDIARY CIMYM NOTIFIES ONCOSCIENCE AG OF INTENTION TO SUBMIT ISSUES FOR ARBITRATION MISSISSAUGA, ON, Nov. 17 /CNW/ - YM...

YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT

YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT MISSISSAUGA, ON, Nov. 13 /CNW/ - YM BioSciences Inc. (NYSE Alternext US:YMI, TSX:YM, AIM:YMBA), an...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

YM Bio.'b'ser1 (YMB)

Empower your portfolio: Real-time discussions and actionable trading ideas.

YMB News

YM BIOSCIENCES NIMOTUZUMAB APPROVED FOR MEXICO MARKETING

YM BIOSCIENCES USA RECEIVES CLEARANCE

YM BioSciences' subsidiary resolves proposed arbitration

Statement re YM BioSciences Reports Daiichi-Sankyo

Clinical study results to be presented at annual meeting

YM BIOSCIENCES ANNOUNCES TRIAL OF NIMOTUZUMAB

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS

Half-yearly Report

Research Update

Statement re

YM BioSciences Announces Milestone Payment

YM BioSciences EU Regulatory Update

Notice of YM Biosciences Annual and Special Meeting

YM BIOSCIENCES - INTENTION - ARBITRATION

YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT

YMB Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

YM Bio.'b'ser1 (YMB) News

YM Bio.'b'ser1 (YMB)

Empower your portfolio: Real-time discussions and actionable trading ideas.

YMB News

YM BIOSCIENCES NIMOTUZUMAB APPROVED FOR MEXICO MARKETING

YM BIOSCIENCES USA RECEIVES CLEARANCE

YM BioSciences' subsidiary resolves proposed arbitration

Statement re YM BioSciences Reports Daiichi-Sankyo

Clinical study results to be presented at annual meeting

YM BIOSCIENCES ANNOUNCES TRIAL OF NIMOTUZUMAB

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS

Half-yearly Report

Research Update

Statement re

YM BioSciences Announces Milestone Payment

YM BioSciences EU Regulatory Update

Notice of YM Biosciences Annual and Special Meeting

YM BIOSCIENCES - INTENTION - ARBITRATION

YM BIOSCIENCES RESPONDS TO BBM ANNOUNCEMENT

YMB Discussion

Your Recent History